Retains ~80% of the carrier fraction
Revolutionising the dry powder inhaler
Our three novel DPI engines are tuneable to different formulation needs and between them cover the broad range of fill masses, whether carrier-based or API-only.
Quattrii
Suitable for
up to 150 mg
fill masses
Highly tuneable to specific formulations
Carrier-based formulations
API-only formulations
Targeted at existing and new low-potency molecules
.svg){kind=icon}
Patent-pending
Clinical devices 2025
Simple to manufacture
Blister-based for high dosing accuracy and inherent moisture protection
Aeolus
Blister-based for high dosing acuracy and inherent moisture protection
Unique pressure-amplification achieves best-in-class flowrate independency
Patented
Carrier-based formulations
API-only formulations
Targeted at existing and new molecules
Suitable for
5 - 50 mg
fill masses
Occorix
ACTIVE
Performance is completely independent of the patient’s inhalation effort
Robust performance, independent of formulation
API-only formulations
Suitable for
1 - 5 mg
fill masses
Targeted at existing and new molecules
Blister-based, for high dosing accuracy and inherent moisture protection
.svg){kind=icon}
Aerosolises molecules down to primary particles
Patented